Study of fasudil treatment of acute ischemic stroke
Lists
Only you see this
Abstract
OBJECTIVE To evaluate the Rho kinase inhibitor fasudil treatment of acute ischemic stroke clinical efficacy and safety.METHODS A randomized controlled study was conducted patients with acute ischemic stroke 160 cases were randomly divided into control group and treatment group.Pateints were given conventional treatment and conventional therapy plus fasudil treatment,14 days for a course of treatment.Assessment of clinical efficacy based on the Fourth National Symposium on cerebrovascular disease in stroke patients through clinical neurological deficits score standards and improved Rankin Scale respectively,before treatment,after 14 days a month for patients score as the clinical efficacy indicators.Safety was estimated.RESULTS 160 cases of patients on the efficacy analysis,treatment group,14-day neurological deficit score and a 30-day modified Rankin score change and the control group the differences were statistically significant,suggesting that fasudil was more effective than the control group,a significant improvement patients with neurological deficits and clinical outcome,and fasudil well tolerated,its adverse reactions were similar to those with the control group.CONCLUSION This study shows that Rho kinase inhibitor fasudil for patients with acute ischemic stroke is safe and effective.
BibTeX
@inproceedings{zhou2009study,
author = {Xuehai Zhou},
title = {{Study of fasudil treatment of acute ischemic stroke}},
booktitle = {Chinese},
year = {2009},
}Loading related content...